aml- lab diagnosis

Upload: bhavyaa-bahl

Post on 03-Jun-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 AML- Lab Diagnosis

    1/57

    PRESENTED BY BHAVYAA BAHL

  • 8/11/2019 AML- Lab Diagnosis

    2/57

    Also known as Acute non-lymphocytic leukemiaGroup of clonal hematopoietic stem cell disorders in which,

    1. Inhibition of terminal myeloid differentiation2. Over proliferation into STEM CELL compartment

    ACCUMULATION OFMYELOBLASTS IN THE

    BONE MARROW

    NORMAL HEMATOPOIETICPROGENITOR CELL

    SUPPRESSED

  • 8/11/2019 AML- Lab Diagnosis

    3/57

    NORMAL HEMATOPOIETICPROGENITOR CELL

    SUPPRESSION

    ANAEMIA

    THROMBOCYTOPENIANEUTROPENIA

    All responsible for

    MAJOR CLINICAL COMPLICATIONS OF AML

  • 8/11/2019 AML- Lab Diagnosis

    4/57

    PATIENT SAMPLE COLLECTION

    1. Blood Sample2. Bone Marrow Sample

    Aspiration Trephine Biopsy

    Blood Cell Counting(P. smear)

    Routine microscopicexamination

    Cytochemistry

    Flow cytometry &immunohistochemistry

    FISH

    PCR

    LABORATORY TESTS

  • 8/11/2019 AML- Lab Diagnosis

    5/57

  • 8/11/2019 AML- Lab Diagnosis

    6/57

    FEATURE ALL AML

    Leukemic blasts Lymphoblasts Myeloblasts

    Size Smaller, 10-15 m Larger, 12-20 m

    N/C Ratio High Low

    Chromatin Clumped Spongy

    Nucleoli

  • 8/11/2019 AML- Lab Diagnosis

    7/57

    FEATURE ALL AML

    MPO Negative Positive

    Sudan Black B Negative Positive

    NSE Negative Positive

    TdT Positive Negative

    PAS Positive (shows block pattern) Positive in

  • 8/11/2019 AML- Lab Diagnosis

    8/57

    CONDITION SPECIFIC MARKERS

    ALL

    T-cell CD1a, CD2, CD3, CD4, CD5,CD7, CD8, CD11b,CD25,CD45,CD56

    B-cell CD10, CD19, CD20,CD21, CD22, CD23,CD79a, Sig, Ig

    NK cell CD16, CD56, CD57

    AML CD13, CD14, CD15 ,CD33, CD41, CD61, CDw65, CD71,

    Glycophorin A, MPO

  • 8/11/2019 AML- Lab Diagnosis

    9/57

    CELL MORPHOLOGY

    MYELOBLASTS 1. Delicate nuclear chromatin

    2. 2-4 nucleoli

    3. Azurophilic, peroxidase +ve granules/Auer rods may

    be present.

    MONOBLASTS 1. Often folded/lobulated nuclei,

    2. NO Auer rods

    3. PODve, NSE +ve

    PROMONOCYTE/

    MONOCYTE

    Abn nuclear maturation, granulation , loss of basophilia.

    ERYTHROID PRECURSORS Normal/varying degrees of dyserythropoiesis

    BASOPHILS Rarely in AML/if present show abnormal granule

    formation & nuclear maturation.

    MEGAKARYOCYTES / . Dysplastic hyperlobated, hypolobated,

    multinuclear, small and blastic forms may be present.

  • 8/11/2019 AML- Lab Diagnosis

    10/57

    STAIN RESULT

    Myeloperoxidase (MPO) Identifies blast cells as myeloid.

    Dysplastic neutrophils may be -ve.

    Eosinophil granules always +ve.

    Monoblasts and promonocytes may be -ve.Sudan Black B Same

    Chloroacetate esterase (CAE) Specifically identifies cells of the granulocyte lineage.

    Non specific estrase (NSE) Specifically identifies cells of the Monoblast lineage.

    Alpha-Naphthyl Acetate

    esterase (ANAE)

    Stains monocytes and megakaryocytes at all stages of

    maturation.

    Toluidine blue Stains the granules of basophils and mast cells.

    Periodic Acid Schiff (PAS) It is not lineage specific but the pattern of staining

    may be helpful

  • 8/11/2019 AML- Lab Diagnosis

    11/57

    Diagnosis is confirmed by staining cells for myeloid specific surface markers

    CELL MARKERS

    Hematopoietic stem cell

    ProgenitorCD34, CD117, TdT

    Myeloid cell CD11b, CD11c, CD13, CD14, CD15, CD16, CD33, CD34, CD38, CD45,CD71,CD123 , CD163, MPO

    T-cell CD1a, CD2, CD3, CD4, CD5,CD7, CD11b, CD25,CD45, CD56, HLA-DR

    B-cell CD10, CD19, CD20,CD21, CD22, CD23,CD79a, SIg, HLA-DR,Ig

    Megakaryocyte CD41, CD61

    Erythrocytes CD 71, CD235a, Glycophorin A

    Neutrophil CD11c, CD15, CDw65, MPO

    Monocytes/Macrophages CD4,CD33, CD64, CD 163, HLA-DR, MPO

    cCD79a-In AML, presence usually represents aberrant B cell antigen in leukemias of distinct myeloidlinage, not biphenotypic differentiation

  • 8/11/2019 AML- Lab Diagnosis

    12/57

    Revised FAB classification of AML

    S.NO CLASS INCIDENCE

    1. M0 Minimally differentiated AML 2-3%

    2. M1 AML without differentiation 20%

    3. M2 AML with maturation 30-40%

    4. M3 Acute promyelocytic leukemia 5-10%

    5. M4 Acute myelomonocytic

    leukemia

    15-20%

    6. M5 Acute monocytic leukemia 10%

    7. M6 Acute erythroleukemia 5%

    8. M7 Acute megakaryocyticleukemia 1%

  • 8/11/2019 AML- Lab Diagnosis

    13/57

    MORPHOLOGYCYTOCHEMISTRYIMMUNOPHENOTYPING

  • 8/11/2019 AML- Lab Diagnosis

    14/57

    1. CLASS 1. CRITERIA

    M0 1. Myeloid blasts >20% of nucleated Bone marrow cells

    2. MPO +ve on ultrastructural cytochemistry

    3. 90% of BM nonerythroid cells (i.e also excluding

    lymphocytes, plasma cells, mast cells & macrophages from the count)

    2. Maturing granulocytic cells (i.e promyelocytes to polymorphonuclear cells)10% of nonerythroid cells

    3. Monocytic cells (monoblasts to monocytes) 20% of BM nucleated cells

    M3 variant 1. Promyelocytes (hypogranular) >20% of BM nucleated cells

  • 8/11/2019 AML- Lab Diagnosis

    15/57

    1. CLASS 1. CRITERIA

    M4 1. Blasts >20% of BM nucleated cells2. Monocytic cells,precursors and neutrophils ,precursors are each more than

    20%.3. MPO +ve >3% blasts.

    4. NSE +ve in cells of monocytic lineage5. CD13, 33 (myeloid); CD14, LYSOZYME (monocytic)

    M5 1. >80% cells in the bone marrow are monocytic (monoblasts, promonocytes& monocytes).

    2. There is intense NSE +vity

    3. CD 14, 36, 64, 11cM6 1. More than 20% of non-erythroid cells are myeloblasts and more than 50%

    of all nucleated cells are erythroblasts Or2. More than 80% of marrow cells are erythroblasts with no significant

    Myeloblastic component3. PAS stain gives a diffuse or block positivity in erythroblasts.

    4. MPO +ve in myeloblasts5. Erythroblasts react with monoclonal antibody against glycophorin A

    M7 1. Megakaryoblasts are 20% or more in the marrow2. Marked bone marrow fibrosis.3. Blasts are platelet peroxidase, CD41 (glycoprotein IIb/IIIA) & CD61

    (glycoprotein III a) +ve

  • 8/11/2019 AML- Lab Diagnosis

    16/57

    MORPHOLOGY CYTOCHEMISTRY IMMUNOPHENOTYPE

    Blasts >20% of nucleatedBM cellsNo evidence of maturation

    CYTOPLASM : Scant

    Grey to light blue in color No granules No Auer rods

    Lack definitivecytological &cytochemical markers

    of myeloblasts .

    NEGATIVE FOR ALL(

  • 8/11/2019 AML- Lab Diagnosis

    17/57

    M0

    Bone marrowaspirate smear,Wright-Giemsa

    stain

  • 8/11/2019 AML- Lab Diagnosis

    18/57

    M0 M0,MPO +ve

  • 8/11/2019 AML- Lab Diagnosis

    19/57

    MORPHOLOGY CYTOCHEMISTRY IMMUNOPHENOTYPE

    1. Blasts vary in size

    2. Nuclei is round to oval/

    irregular

    3. Scant, Agranular usually, blue-

    grey cytoplasm4. Auer rods few

    5. In this setting, if Auer rods are

    seen, the diagnosis of M1

    AML is established.

    *By morphology alone, M1 blastscannot be distinguished from

    M0, agranular M2 blasts or L2

    blasts.

    MPO,SB PAS NSE

    Bu CD 13CD33CD34

    CD19CD117HLA-DR

    >3% - - -

  • 8/11/2019 AML- Lab Diagnosis

    20/57

    M1

    Bone marrowaspirate smear,Wright-Giemsa

    stain

  • 8/11/2019 AML- Lab Diagnosis

    21/57

    M1, MPO+ve M1

  • 8/11/2019 AML- Lab Diagnosis

    22/57

    MORPHOLOGY CYTOCHEMISTRY IMMUNOPHENOTYPE

    Maturation down the granulocytic

    line

    Cells beyond Promyelocyte

    Differentiated neutrophils, some

    eosinophils,and rarely basophilsMaturing cells are dysplastic

    (mostly)

    Nuclear chromatin coarser,

    clumped

    Type II blasts significant in number

    Unlike normal promyelocytes andearly myelocytes, the Golgi

    apparatus is poorly developed.

    Nuclear maturation lags behind

    the cytoplasmic maturation.

    Auer rods are frequently visible.

    MPO,SB PAS NSE CAE CD 13CD33CD34

    CD99CD117HLA-DR

    CD56CD19

    >3% - - +

  • 8/11/2019 AML- Lab Diagnosis

    23/57

    A variant associated with eosinophilia

    The eosinophils may show mild

    atypia, particularly in the more

    immatures ones, characterized by the

    appearance of coarse cytoplasmic

    granules ranging in color from deeply

    basophilic, resembling primary or

    basophil granules to those that have a

    salmon-like color.

    The more mature eosinophils usually

    are not atypical.

    A very rare subtype, is also an

    example of AML with differentation-

    in this case down the basophil lineage.

    The leukemic blasts are type II and the

    cytoplasmic granules are coarse and

    basophilic, resembling those in

    normal mature basophils, and the

    cytoplasm is basophilic in color and

    may contain vacuoles.

    Some of the more mature forms often

    are dysplastic

  • 8/11/2019 AML- Lab Diagnosis

    24/57

    M2AUER ROD

  • 8/11/2019 AML- Lab Diagnosis

    25/57

    M2

    Bone marrowaspirate smear,Wright-Giemsastain

  • 8/11/2019 AML- Lab Diagnosis

    26/57

    M2 AML with

    eosinophilia

    (M2Eo)

    Bone marrowaspirate smear,

    Wright-Giemsa stain

  • 8/11/2019 AML- Lab Diagnosis

    27/57

    Sudan black B +ve blasts, stronger in dysplasticmetamyelocytes.Inset: Chloroacetate in maturing granulocytes.

  • 8/11/2019 AML- Lab Diagnosis

    28/57

    MORPHOLOGY CYTOCHEMISTRY IMMUNOPHENOTYPE

    Arrest at the promyelocyte -

    late myelocyte stage

    Cell size & shape vary

    Poorly developed Golgi

    apparatus

    Variable nuclear:cytoplasmic

    ratio

    Cytoplasmic color - light blue to

    pink, variable number of granules

    that may have a pink, red, or dark

    purple color. The granules may

    obscure the nucleus.Auer rods & Faggot cells seen

    Round, oval, indented, reniform,

    Angel winglike nucleus

    The nuclear chromatin -coarse,

    clumped

    Nucleoli may /may not be visible.

    MPO,SB

    CAE PAS NSE Bu CD2CD4CD11cCD13

    CD33CD34CD45CD56CD64CD117

    + + - - -

  • 8/11/2019 AML- Lab Diagnosis

    29/57

    HYPERGRANULAR HYPOGRANULAR / MICROGRANULAR

    Most common subtype, 80% of cases

    Cytoplasmic granulation prominentLarge (giant) granules may be seenBlasts vary in sizeAuer rods are common

    Granulation sparce, in some cells

    granules are not seen on a Wright-Giemsa stainDistinct morphological features such asbilobed nucleusAuer rods less frequent(confused with monoblast)

  • 8/11/2019 AML- Lab Diagnosis

    30/57

    M3 AMLwith

    Auer rods

    Bone marrowaspirate smear,Wright-Giemsastain

  • 8/11/2019 AML- Lab Diagnosis

    31/57

    M3

    Bone marrowaspirate smear,Wright-Giemsastain

  • 8/11/2019 AML- Lab Diagnosis

    32/57

    M3 Angel wingnucleus

  • 8/11/2019 AML- Lab Diagnosis

    33/57

    M3HYPOGRANULAR

    Bone marrowaspirate smear,

    Wright-Giemsa stain

  • 8/11/2019 AML- Lab Diagnosis

    34/57

    Sudan black B +veTypical heavy cytoplasmic

    positivity

    Promyelocyte CAE +ve (blue)Inset: atypical ANAE +ve 1%of M3

    cases.

  • 8/11/2019 AML- Lab Diagnosis

    35/57

    MORPHOLOGY CYTOCHEMISTRY IMMUNOPHENOTYPE

    Appear as typical myeloblasts ormonoblasts/promonocytes, & cellsthat are difficult to categorize asbelonging to either lineage .Depending upon which lineage they

    appear like the following varies,1. Size & shape2. The cytoplasm-

    Scant- Myeloblasts likeAbundant- Monocytic like

    3. N:C ratio4. Nucleus variable in size and shape

    5. Nucleoli prominent in those withmonoblastic and promonocyticfeatures.

    In the more differentiated cells,cytoplasmic granules that resemblepromonocytes (fine granulation with a"salt and pepper" appearance)Auer rodsmay be seen

    MPO,SB

    CAE PAS NSE Bu Myeloid lineageCD13+CD33

    Monocyte lineageCD4CD14+CD116CD11c

    Lysozyme

    + + - + +

  • 8/11/2019 AML- Lab Diagnosis

    36/57

    1. May represent up to 10% of all adult AMLs2. Usually occurs at a younger age3. Variable number of differentiating eosinophils present

    4. Eosinophils are atypical (dysplastic). More matureeosinophils are less atypical5. Coarse basophilic granules seen with a variable number

    of eosinophilic granules.6. The morphologic picture is diagnostic and is associated

    with the inv(16) cytogenetic abnormality.

  • 8/11/2019 AML- Lab Diagnosis

    37/57

    M4 Someblasts withmyeloblastic

    features andsome withmonoblastic

    Bone marrowaspirate smear,Wright-Giemsastain,

  • 8/11/2019 AML- Lab Diagnosis

    38/57

    M4Eo AMLwithatypical

    youngeosinophils

  • 8/11/2019 AML- Lab Diagnosis

    39/57

    M4E0

  • 8/11/2019 AML- Lab Diagnosis

    40/57

    M4 AML

    MPO +ve

    M4 AML

    Sudan Black B +ve

  • 8/11/2019 AML- Lab Diagnosis

    41/57

    M4, NSE +ve

  • 8/11/2019 AML- Lab Diagnosis

    42/57

    CATEGORY M5aMONOBLASTIC,Undifferentiated

    M5bMONOCYTIC, Differentiated

    1. Predominant cell type2. Size3. Cytoplasm

    4. Vacuole5. Auer rods6. Nucleus7. Chromatin8. Nucleoli

    9. Erythrophagocytosis

    Monoblast1-1.5 times neutrophil sizeAbundant, color ranges froma medium to dark blue

    PresentAbVaries in shape n sizeFine1 or

  • 8/11/2019 AML- Lab Diagnosis

    43/57

    TYPE CYTOCHEMISTRY IMMUNOPHENOTYPE

    M5a

    Vacuoles are PAS +veMPO,SB ANAE PAS NSE Bu Stem cell/hematopoietic

    progenitor cell

    CD34-

    HLA-DR -

    Monocytic lineage

    CD4,

    CD14

    CD11c

    CD64

    CD68

    CD116lysozyme

    Myeloid lineage

    CD33

    CD13

    CD117

    - + - + +

    M5b

    Both nuclear & cytoplasmic

    differentiation

    +/- + - + +

  • 8/11/2019 AML- Lab Diagnosis

    44/57

    M5a

  • 8/11/2019 AML- Lab Diagnosis

    45/57

    M5 AMLNon-specific esterase (NSE) stain

  • 8/11/2019 AML- Lab Diagnosis

    46/57

    M5b

    M6a : Proerythroblasts mixed with myeloblasts

  • 8/11/2019 AML- Lab Diagnosis

    47/57

    TYPE CYTOCHEMISTRY IMMUNOPHENOTYPE

    Dysplastic proerythroblasts

    predominate Varied-size and shape Presence of bizarre, giant

    forms Megaloblastic & dysplastic

    nuclear features prominent,including multilobated nucleiwith Howell-Jolly bodies

    Marked lag in nuclearmaturation wrt cytoplasmic

    Vacuoles prominent On Fe stain, ring sideroblasts A myeloblastic component

    may be present, tendency totransform to either an M1, M2,or M4 subtype with time

    MPO,SB CAE PAS NSE GlyA Stemcell/hematopoietic

    progenitor cell

    CD34-

    HLA-DR-Erythroid lineage

    Glycophorin A +ve

    Myeloid lineage

    CD13+

    CD33+

    CD117+Monocytic lineage

    CD4+

    CD14+

    CD11b+

    CD11a+

    CD64+

    +/-

    (M6a)-

    (M6b)

    +/-

    -

    +

    +

    +/-

    (M6a)-

    (M6b)

    +

    +

    y y

    M6b : Proerythroblasts

  • 8/11/2019 AML- Lab Diagnosis

    48/57

    M6a AML withmyeloblasts &erythroblasts

    Bone marrow aspiratesmear, Wright-Giemsa stain

  • 8/11/2019 AML- Lab Diagnosis

    49/57

    M6b AML withmultiple Howell-Jollybodies-

    M6a AML - myeloblasts& erythroblasts andwith many cytoplasmicvacuoles

    M6

  • 8/11/2019 AML- Lab Diagnosis

    50/57

    M6a

    PAS+ve

  • 8/11/2019 AML- Lab Diagnosis

    51/57

    M6b

  • 8/11/2019 AML- Lab Diagnosis

    52/57

    Giant multinucleate late

    normoblasts

    PAS +veGranular in proerythroblasts

    Homogeneous in normoblasts

  • 8/11/2019 AML- Lab Diagnosis

    53/57

    TYPE CYTOCHEMISTRY IMMUNOPHENOTYPE

    Variable

    Microblasts like lymphoblasts

    a. Irregular cytoplasmic blebs

    b. Membrane projections

    c. Fine cytoplasmic granules(micromegakaryoblastic subtype)

    or very heterogenous population

    of blasts including,

    a. Large megakaryoblasts

    b. Blue cytoplasm

    c. With/without nuclear lobation& cytoplasmic granules

    On a biopsy specimen, fibrosis,

    ranging from reticulin to

    collagenous seen.

    MPO,SB PAS NSE AP Stem cell/hematopoieticprogenitor cell

    CD34-

    HLA-DR-

    *CD45-Myeloid lineage(may be +ve)

    CD13

    CD33

    Megakaryocyte lineage

    CD41 (glycoprotein IIb/IIIa)

    CD61 (glycoprotein IIIA)CD36 (glycoprotein IIIb)

    Platelet Peroxidase +ve

    - + + +

    *Common Leukocyte Antigen CD45 is NEGATIVE

    M AML

  • 8/11/2019 AML- Lab Diagnosis

    54/57

    M7 AMLMicromegak

    -aryoblasticsubtype

    Bone marrow aspiratesmear, Wright-Giemsastain

  • 8/11/2019 AML- Lab Diagnosis

    55/57

    M7

  • 8/11/2019 AML- Lab Diagnosis

    56/57

    M7 AML with large,immature andbilobedmegakaryoblast

    Peripheral bloodsmear, Wright-Giemsa stain

  • 8/11/2019 AML- Lab Diagnosis

    57/57